I thought monoclonals were given the first 10 days after onset of the virus in order to be effective and avoid hospitalization. Keeping them to treat severe patients would be wasting them on patients who cannot benefit. This sounds like the CDC, again!
Monoclonals have to be used before blood oxygen levels drop. The cutoff used to be 94%. Outcomes are reported to be worse than not using them if O2 has fallen too low.
People who require hospitalization have already fallen below the minimum. That’s why they aren’t given to the seriously ill. They have missed the window of opportunity.
what the article is saying is, Regeneron, and the Eli Lilly one, cassie something, are not effective against Omi. So they’re pulling them.
(which is kind of wierd since Delta is still out there and Regen and ELilly both work against Delta)
And that “ sotrovimab” can still fight Omi, but it’s too limited in production right now for widespread availability because of unexpected demand.
In the General/Chat forum, on a thread titled Hospitals in New York region say they've run out of antibody treatment for omicron variant, the_Watchman wrote: |
I thought monoclonals were given the first 10 days after onset of the virus in order to be effective and avoid hospitalization. Keeping them to treat severe patients would be wasting them on patients who cannot benefit. This sounds like the CDC, again! |